Same-day initiation of ART feasible and safe without CD4 counts, Thai study shows
Treating drug addiction may reduce risk of viral rebound
Curing hepatitis C may reduce inflammation in people with HIV
Barriers to PrEP implementation for transgender people worldwide
Cash payments to stay in school reduce HIV incidence in girls and young women, eSwatini study finds
Punitive laws associated with HIV infections in female sex workers
High and increasing HIV incidence in young Latin American gay men
Leakages in ART treatment cascades in West Africa and Zambia
Dramatic decline in proportion of people with extensive resistance to anti-HIV medications
Young adults with vertical HIV and hepatitis C co-infection have a high hepatitis C cure rate
13% of HIV-positive Europeans who are cured of hepatitis C are reinfected
Could a better understanding of inflammation help research towards an HIV cure?
Same-day initiation of PrEP feasible and safe in Latin America
Without frequent viral load monitoring dolutegravir-based regimens not the best choice for African youth on failing ART
HIV outcomes for transgender women improved by addressing social and structural issues
'Mystery shoppers' in Kenyan pharmacies highlight issues with distribution of HIV self-tests
Fostemsavir salvage therapy continues to look good at 96 weeks
Dolutegravir dual therapy works well for both first line and maintenance treatment
